Medicure Return on Equity (ROE) Growth & History (MCUJF)
Medicure's return on equity was −42.13% for fiscal 2025.
View full Medicure company overviewMedicure annual return on equity history
| Fiscal year | Period ended | Return on equity | Change (percentage points) |
|---|---|---|---|
| 2025 | 2025-12-31 | −42.13% | −37.03 pp |
| 2024 | 2024-12-31 | −5.11% | −0.60 pp |
| 2023 | 2023-12-31 | −4.51% | −11.43 pp |
| 2022 | 2022-12-31 | 6.93% | +10.80 pp |
| 2021 | 2021-12-31 | −3.87% | +25.83 pp |
| 2020 | 2020-12-31 | −29.70% | +6.10 pp |
| 2019 | 2019-12-31 | −35.80% | −40.58 pp |
| 2018 | 2018-12-31 | 4.78% | −69.51 pp |
| 2017 | 2017-12-31 | 74.29% | −58.45 pp |
| 2016 | 2016-12-31 | 132.74% | — |
Medicure quarterly return on equity
| Fiscal quarter | Period ended | Return on equity | Change (percentage points) |
|---|---|---|---|
| Q2 2026 | 2026-06-30 | −11.79% | −7.70 pp |
| Q1 2026 | 2026-03-31 | −3.18% | +0.22 pp |
| Q4 2025 | 2025-12-31 | −27.94% | — |
| Q3 2025 | 2025-09-30 | −7.84% | — |
| Q2 2025 | 2025-06-30 | −4.09% | — |
| Q1 2025 | 2025-03-31 | −3.40% | — |
Medicure return on equity trends
Over the last five fiscal years, Medicure's return on equity decreased from −29.70% to −42.13%, a change of −12.43 percentage points. The latest reported quarter, Q2 2026, shows −11.79%.
What return on equity (ROE) means
Return on equity (ROE) measures how much net income a company generates relative to shareholders’ equity. It can help evaluate how efficiently equity capital is used, but unusually high or negative values may reflect leverage, losses, or a small equity base.
How return on equity is calculated
TickerStat calculates ROE as SEC-reported net income divided by average stockholders’ equity at the beginning and end of the fiscal period. Periods with missing or non-positive average equity are omitted. Quarterly ROE uses quarterly net income and is not annualized. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Medicure source filings ↗